An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
View ORCID ProfileBongkot Ngamsom, View ORCID ProfileAlexander Iles, View ORCID ProfileMoses Kamita, View ORCID ProfileRacheal Kimani, View ORCID ProfilePablo Rodriguez-Mateos, View ORCID ProfileMary Mungai, View ORCID ProfileCharlotte E. Dyer, View ORCID ProfileCheryl Walter, View ORCID ProfileJesse Gitaka, View ORCID ProfileNicole Pamme
doi: https://doi.org/10.1101/2022.01.06.22268835
Bongkot Ngamsom
aDepartment of Chemistry and Biochemistry, University of Hull, Hull, HU6 7RX, UK
Alexander Iles
aDepartment of Chemistry and Biochemistry, University of Hull, Hull, HU6 7RX, UK
Moses Kamita
bDirectorate of Research and Innovation, Mount Kenya University, Thika, Kenya
Racheal Kimani
bDirectorate of Research and Innovation, Mount Kenya University, Thika, Kenya
Pablo Rodriguez-Mateos
aDepartment of Chemistry and Biochemistry, University of Hull, Hull, HU6 7RX, UK
Mary Mungai
cCentre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
Charlotte E. Dyer
dDepartment of Biomedical Sciences, University of Hull, Hull, HU6 7RX, UK
Cheryl Walter
dDepartment of Biomedical Sciences, University of Hull, Hull, HU6 7RX, UK
Jesse Gitaka
bDirectorate of Research and Innovation, Mount Kenya University, Thika, Kenya
Nicole Pamme
aDepartment of Chemistry and Biochemistry, University of Hull, Hull, HU6 7RX, UK
eDepartment of Materials and Environmental Chemistry, Stockholm University, SE-106 91, Sweden
Posted January 06, 2022.
An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
Bongkot Ngamsom, Alexander Iles, Moses Kamita, Racheal Kimani, Pablo Rodriguez-Mateos, Mary Mungai, Charlotte E. Dyer, Cheryl Walter, Jesse Gitaka, Nicole Pamme
medRxiv 2022.01.06.22268835; doi: https://doi.org/10.1101/2022.01.06.22268835
An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
Bongkot Ngamsom, Alexander Iles, Moses Kamita, Racheal Kimani, Pablo Rodriguez-Mateos, Mary Mungai, Charlotte E. Dyer, Cheryl Walter, Jesse Gitaka, Nicole Pamme
medRxiv 2022.01.06.22268835; doi: https://doi.org/10.1101/2022.01.06.22268835
Subject Area
Subject Areas
- Addiction Medicine (367)
- Allergy and Immunology (688)
- Anesthesia (184)
- Cardiovascular Medicine (2740)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12386)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4252)
- Geriatric Medicine (394)
- Health Economics (699)
- Health Informatics (2749)
- Health Policy (1017)
- Hematology (369)
- HIV/AIDS (878)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4026)
- Nursing (216)
- Nutrition (598)
- Oncology (2122)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (311)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (477)
- Pediatrics (1146)
- Primary Care Research (465)
- Public and Global Health (6644)
- Radiology and Imaging (1444)
- Respiratory Medicine (886)
- Rheumatology (420)
- Sports Medicine (351)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)